MARISSA GONZALEZ: Open Payments
NPI 1346983137 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 18 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $397 · 2025 $594
Food & beverage: $363Education: $231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Astellas Pharma US Inc | 1 | $100 |
| SEAGEN INC. | 1 | $100 |
| Celgene Corporation | 3 | $65 |
| PFIZER INC. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Caris MPI, Inc. | 1 | $15 |
| Exelixis Inc. | 1 | $15 |
Products named: ENHERTU, IBRANCE, REBLOZYL, PLUVICTO, KEYTRUDA, OPDIVO, MI CANCER SEEK, Stivarga.
Industry payments across TX — which companies pay providers there.
